Michael Gerard's most recent trade in ContextLogic Inc - Ordinary Shares - Class A was a trade of 23,740 Restricted Stock Units done . Disclosure was reported to the exchange on June 30, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ContextLogic Inc - Ordinar... | Michael Gerard Scarola | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 23,740 | 23,740 | - | - | Restricted Stock Units | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 112,500 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 75,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 112,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Michael Gerard | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |